CMP PHARMA INC FDA Approval ANDA 087859

ANDA 087859

CMP PHARMA INC

FDA Drug Application

Application #087859

Application Sponsors

ANDA 087859CMP PHARMA INC

Marketing Status

Prescription001

Application Products

001SUSPENSION;ORAL, RECTAL15GM/60ML0SPSSODIUM POLYSTYRENE SULFONATE

FDA Submissions

ORIG1AP1982-12-08
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1985-12-12
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1987-07-16
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1989-07-18
LABELING; LabelingSUPPL13AP1991-12-12
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1991-05-31
MANUF (CMC); Manufacturing (CMC)SUPPL18AP2000-11-30
LABELING; LabelingSUPPL20AP2004-03-18
LABELING; LabelingSUPPL23AP2011-03-03
LABELING; LabelingSUPPL24AP2011-03-03
LABELING; LabelingSUPPL25AP2011-06-24

Submissions Property Types

SUPPL1Null0
SUPPL3Null0
SUPPL10Null0
SUPPL12Null0
SUPPL14Null0
SUPPL18Null0
SUPPL25Null7

TE Codes

001PrescriptionAA

CDER Filings

CMP PHARMA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 87859
            [companyName] => CMP PHARMA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"SPS","activeIngredients":"SODIUM POLYSTYRENE SULFONATE","strength":"15GM\/60ML","dosageForm":"SUSPENSION;ORAL, RECTAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"Yes"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"SPS","submission":"SODIUM POLYSTYRENE SULFONATE","actionType":"15GM\/60ML","submissionClassification":"SUSPENSION;ORAL, RECTAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.